The percentage of rectal epithelial cells co-expressing CCL20 and CCR6 was 20.4% of all the patients, including 23.4% (18/77) of patients without neoplasia and 6.3% (1/16) of patients with UC-associated neoplasia. The gene discussed is CCR6; the disease is neoplasm.